WO2016187950A1 - Primary-level medical platform and diabetes patient monitoring method based on primary-level medical platform - Google Patents

Primary-level medical platform and diabetes patient monitoring method based on primary-level medical platform Download PDF

Info

Publication number
WO2016187950A1
WO2016187950A1 PCT/CN2015/085625 CN2015085625W WO2016187950A1 WO 2016187950 A1 WO2016187950 A1 WO 2016187950A1 CN 2015085625 W CN2015085625 W CN 2015085625W WO 2016187950 A1 WO2016187950 A1 WO 2016187950A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood glucose
user
monitoring
platform
preset
Prior art date
Application number
PCT/CN2015/085625
Other languages
French (fr)
Chinese (zh)
Inventor
张贯京
陈兴明
葛新科
张少鹏
方静芳
普拉纽克•克里斯基捏
古列莎•艾琳娜
波达别特•伊万
王海荣
高伟明
李慧玲
Original Assignee
深圳市共创百业科技开发有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳市共创百业科技开发有限公司 filed Critical 深圳市共创百业科技开发有限公司
Publication of WO2016187950A1 publication Critical patent/WO2016187950A1/en

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Definitions

  • the present invention relates to the field of medical technology, and in particular, to a primary medical platform and a monitoring method for a diabetic based on a primary medical platform.
  • the main objective of the present invention is to provide a primary medical platform and a monitoring method for a diabetic based on a primary medical platform, which can comprehensively intervene and remind the implementation of the diagnosis and treatment plan for the diabetic patient, thereby improving the treatment progress and treatment for the diabetic patient. effect.
  • the present invention provides a method for monitoring a diabetic person based on a primary medical platform, the monitoring method comprising the following steps:
  • the primary medical platform monitors the user's blood glucose level at a preset time in a preset monitoring period according to the user medical treatment plan obtained from the network hospital platform;
  • the primary medical platform compares the blood glucose level of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and counts the comparison result within the preset monitoring period;
  • the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to execute the blood sugar adjusting plan.
  • the step of monitoring, by the primary medical platform, the blood glucose level of the user at the preset time in the preset monitoring period according to the user medical treatment plan acquired from the network hospital platform comprises:
  • the primary medical platform sends an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan within a preset monitoring period;
  • the primary medical platform receives the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzes and manages the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
  • the primary medical platform determines a blood glucose monitoring result in the monitoring period according to a comparison result in a preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user, where the user performs the blood glucose adjustment
  • the steps of the plan specifically include:
  • the primary medical platform determines different conditions when the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of postprandial blood glucose values above or below the postprandial blood glucose threshold is greater than a preset number of thresholds Corresponding blood glucose monitoring results;
  • the primary medical platform matches the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user treatment plan, and sends the matched blood glucose adjustment plan to the user for the user to execute the blood sugar adjustment plan.
  • the monitoring method further includes: before the step of monitoring the blood glucose level of the user at the preset time in the preset monitoring period, according to the user medical treatment plan acquired from the network hospital platform, the monitoring method further includes:
  • the primary medical platform is connected with the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the relevant information of the user.
  • the primary medical platform sends the blood glucose adjustment plan to the user, after the step of the user performing the blood glucose adjustment plan, the monitoring method further includes the step :
  • the primary care platform marks and stores the blood glucose values for a preset time above or below the blood glucose threshold.
  • the present invention also provides a primary medical platform for a diabetes monitoring method, the primary medical platform comprising:
  • the blood glucose monitoring module is configured to monitor a blood glucose value of the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform;
  • the comparison and statistics module is configured to compare the blood glucose value of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and compare the comparison result in the preset monitoring period;
  • the plan sending module is configured to determine a blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and send a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user, where the user performs the blood sugar adjusting plan.
  • the plan sending module is specifically configured to:
  • a preset monitoring period such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high
  • the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, determining corresponding conditions Blood glucose monitoring results;
  • the primary medical platform further comprises:
  • the obtaining module is configured to connect with the network hospital platform, and obtain the user medical treatment plan corresponding to the user according to the related information of the user.
  • the primary medical platform further comprises:
  • a marking and storage module for marking and storing blood glucose values for a preset time above or below a blood glucose threshold.
  • the invention acquires a user diagnosis and treatment plan from the network hospital platform through the primary medical platform, and monitors the blood sugar value of the user at a preset time in a preset monitoring period, and compares the blood glucose value of the user at the preset time with the corresponding time in the user diagnosis plan.
  • the blood glucose threshold is compared, and the comparison result in the preset monitoring period is counted, the blood glucose monitoring result in the monitoring period is determined according to the comparison result in the monitoring period, and the blood glucose adjusting plan corresponding to the blood glucose monitoring result is sent to the user for the user Perform a blood glucose adjustment program.
  • relevant parameters monitoring, reminding and intervention intervention for diabetic patients are carried out according to the user's medical treatment plan, thereby improving the treatment progress and treatment effect for diabetic patients.
  • FIG. 1 is a schematic flow chart of a first embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention
  • FIG. 2 is a schematic diagram of a refinement process of step S10 in FIG. 1;
  • step S30 in FIG. 1 is a schematic diagram of a refinement process of step S30 in FIG. 1;
  • FIG. 4 is a schematic flow chart of a second embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention
  • FIG. 5 is a schematic flow chart of a third embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention.
  • FIG. 6 is a schematic structural view of a first embodiment of a primary medical platform according to the present invention.
  • FIG. 7 is a schematic structural view of a second embodiment of a primary medical platform according to the present invention.
  • FIG. 8 is a schematic structural view of a third embodiment of a primary medical platform according to the present invention.
  • the monitoring method for diabetics obtaineds the corresponding user diagnosis and treatment plan of the diabetic patient through the docking of the primary medical platform and the network hospital platform, and performs related parameter monitoring, reminding and performing intervention on the diabetes patient according to the user diagnosis and treatment plan to improve Treatment progress and treatment effects for diabetic patients.
  • FIG. 1 is a schematic flowchart diagram of a first embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention.
  • the diabetes monitoring method based on the primary medical platform includes:
  • Step S10 The primary medical platform monitors the blood glucose level of the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform;
  • the primary medical platform proposed by the embodiments of the present invention may be a medical institution installed in a township, a village, or the like, or may be a medical institution such as a social health clinic or a clinic set in a community or a community, and the primary medical platform collects the locality or The basic information of all residents of the community or community and the medical information such as the medical history of the resident are monitored by the primary medical platform for chronically ill patients under its jurisdiction.
  • a method for monitoring a diabetic person by a primary medical platform is taken as an example for description.
  • the primary medical platform obtains the user's corresponding medical treatment plan from the network hospital platform, and the user medical treatment plan is a medical treatment intervention plan formed for each diabetic person stored in the database of the network hospital platform, and the medical treatment plan may include the user visiting the hospital.
  • the primary medical platform monitors the blood glucose level of the user within a monitoring period according to a preset monitoring period in the user's medical treatment plan, for example, monitoring the blood glucose level of the user within one week or 10 days, and the preset time is specifically referred to as corresponding The user's blood glucose monitoring time point.
  • Step S20 The primary medical platform compares the blood glucose level of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and counts the comparison result within the preset monitoring period;
  • the primary medical platform After monitoring the blood glucose level of the user at the preset time, the primary medical platform matches the blood glucose threshold of the corresponding time in the user diagnosis plan, and compares the blood glucose value of the preset time with the blood glucose threshold corresponding to the time to determine the user. The blood glucose level at this time is too high or too low.
  • the primary care platform also counts the blood glucose comparison results within a preset monitoring period to analyze the blood glucose monitoring results during the monitoring period after the monitoring period ends.
  • step S30 the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to perform the blood sugar adjusting plan.
  • the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the monitoring period, that is, according to the blood glucose level of the user at the preset time within a preset monitoring period. Continuous monitoring to determine if the blood glucose level during the monitoring period is stable, whether it continues to be above the blood glucose threshold, or continues below the blood glucose threshold.
  • the blood glucose monitoring result is determined, and the primary medical platform matches the user's medical treatment plan according to the corresponding situation of the blood glucose monitoring result, matches the blood glucose adjustment plan corresponding to the blood glucose monitoring result, and sends it to the user for the user to follow the blood sugar adjustment plan.
  • the content is executed to achieve basic monitoring of the user's blood glucose level and monitoring of the implementation of the treatment plan.
  • the blood glucose adjustment plan includes at least one of a drug treatment plan, a diet plan, an exercise plan, and a treatment cycle, and the user can perform the drug treatment according to the guidance of the blood sugar adjustment plan, and adopts the diet plan and the exercise plan as the diet plan and the exercise plan.
  • the content of the blood glucose adjustment plan is executed during the treatment cycle.
  • the embodiment of the invention acquires the user diagnosis and treatment plan from the network hospital platform through the primary medical platform, and monitors the blood glucose value of the user at the preset time in the preset monitoring period, and corresponds the blood glucose value of the user at the preset time to the user diagnosis plan.
  • the blood glucose threshold of the time is compared, and the comparison result in the preset monitoring period is counted, the blood glucose monitoring result in the monitoring period is determined according to the comparison result in the monitoring period, and the blood glucose adjusting plan corresponding to the blood glucose monitoring result is sent to the user, Allows the user to perform a blood glucose adjustment program.
  • relevant parameters monitoring, reminding and intervention intervention for diabetic patients are carried out according to the user's medical treatment plan, thereby improving the treatment progress and treatment effect for diabetic patients.
  • step S10 is a schematic diagram of the refinement process of step S10 in FIG.
  • step S10 specifically includes: Step S101: The primary medical platform sends an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan within a preset monitoring period; Step S102: The primary medical platform receives the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzes and manages the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
  • the primary medical platform After obtaining the user's medical treatment plan of the user, the primary medical platform sends an acquisition instruction to the monitoring device for collecting the blood sugar level of the user according to the preset monitoring time of each day in the preset monitoring period, and the monitoring device has The communication function blood glucose meter can communicate with the primary medical platform, receive the acquisition instruction sent by the primary medical platform, and feed back the measured blood sugar value of the user to the primary medical platform.
  • the monitoring device collects the fasting blood sugar value and the postprandial blood sugar value of the user, and specifically, it is preferable to collect the fasting blood sugar value of the user before the meal in the morning and the postprandial blood sugar value after eating the breakfast for two hours, because the blood sugar values at the two time points are more It can accurately reflect the user's blood sugar condition, and the monitoring device will send the collected fasting blood glucose value and postprandial blood glucose value to the primary medical platform.
  • the primary medical platform records the daily fasting blood glucose level and postprandial blood glucose value of the user in the monitoring period; and compares the fasting blood glucose level and the postprandial blood glucose value with the corresponding blood glucose threshold, and records each in the monitoring period. The results of the comparison are based on the statistical analysis of the comparison results within a monitoring period to determine the blood glucose monitoring results during the monitoring period.
  • step S30 specifically includes: Step S301, in a preset monitoring period, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold, and/or the postprandial blood glucose value is continuously higher or lower than the postprandial blood glucose threshold, or, such as, fasting
  • Step S301 in a preset monitoring period, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold, and/or the postprandial blood glucose value is continuously higher or lower than the postprandial blood glucose threshold, or, such as, fasting
  • the primary medical platform when the blood glucose level is higher or lower than the fasting blood glucose threshold than the preset threshold, and/or the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than the preset threshold Determine the blood glucose monitoring results corresponding to different situations;
  • the primary medical platform determines the blood glucose monitoring result during the monitoring period according to the comparison result in the preset monitoring period, specifically, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold value during the entire monitoring period, and / or the postprandial blood glucose level is continuously higher or lower than the postprandial blood glucose threshold, it can be determined that the blood glucose monitoring result for the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold; or, such as fasting blood glucose
  • the value of the value above or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, and may also be determined
  • the blood glucose monitoring result of the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold, and the preset number of times can be set according to the number of days of the monitoring period.
  • the preset number of times may be 4 times, that is to say, during the monitoring period of one week, if the number of times the blood glucose level is higher or lower than the blood glucose threshold is greater than 4 times, the blood of the user during the monitoring period can be considered.
  • the result of sugar monitoring is that the blood glucose level continues to be above or below the blood glucose threshold.
  • the blood glucose monitoring result for the user during the monitoring period is The blood glucose level is stable.
  • the primary medical platform only needs to record the user's fasting blood glucose level and/or postprandial blood glucose value and blood glucose monitoring result.
  • the user can also send the blood glucose monitoring result to the blood glucose value stable prompt message. And continue to monitor the user's blood glucose level at the preset time in the next monitoring cycle to achieve long-term monitoring and intervention for diabetic patients.
  • Step S302 the primary medical platform matches the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user diagnosis plan, and sends the matched blood sugar adjustment plan to the user for the user to perform the blood sugar adjustment plan.
  • the blood glucose monitoring result is determined for the user during the monitoring period, and the primary medical platform matches the determined blood glucose monitoring plan corresponding to the determined blood glucose monitoring result in the user medical treatment plan.
  • the user's medical treatment plan stores the blood sugar level for the user.
  • the blood glucose adjustment plan of all the cases that may occur after determining the blood glucose monitoring result of the user, the primary medical platform matches the blood glucose adjustment plan corresponding to the corresponding blood glucose monitoring result in the user medical treatment plan, and sends the blood sugar adjustment plan to the user, specifically It can be sent to the user's smart terminal or monitoring device for collecting the user's blood sugar value by text, voice or video to remind the user to follow the various schemes in the blood glucose adjustment plan.
  • the primary medical platform uploads the blood glucose monitoring result to the network hospital platform for analysis and diagnosis by the doctor on the network hospital platform side. And adjust or regenerate the glycemic adjustment plan based on the results of the analysis and diagnosis.
  • FIG. 4 is a schematic flowchart diagram of a second embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention.
  • the monitoring method further includes: In step S40, the primary medical platform is connected to the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the related information of the user.
  • the primary health care platform Before the primary health care platform monitors the diabetics under its jurisdiction, it first connects to the network hospital platform. Specifically, it can be connected to the network hospital platform by entering the login account and login password. After the network hospital platform is verified, it can be based on The user-related information of the user to be obtained is obtained in the network hospital.
  • the related information of the user may include basic information such as the user's name, gender, or the unique registered number of the user on the network hospital platform, or the location of the user, or the living information of the community or the community, and the primary medical platform according to the related information. Obtaining a user diagnosis plan corresponding to the user from the network hospital platform to perform blood glucose monitoring on the user.
  • FIG. 5 is a schematic flowchart diagram of a third embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention. Based on the first embodiment of the present invention, in the third embodiment, after performing the foregoing step S30, the monitoring method further includes: In step S50, the primary medical platform marks and stores the blood glucose value of the preset time above or below the blood glucose threshold.
  • the blood glucose value is marked And storing, in particular, the blood glucose value can be marked by color marking or highlighting, and stored for later clearing to reflect the time and blood sugar level corresponding to the abnormal blood sugar value of the user.
  • the blood glucose value can also be transmitted to the network hospital platform for the doctors on the network hospital platform side to perform relevant statistics and marking.
  • FIG. 6 is a schematic structural view of a first embodiment of a primary medical platform according to the present invention.
  • the primary medical platform includes: a blood glucose monitoring module 10, configured to monitor a blood glucose value of the user at a preset time in a preset monitoring period according to a user medical treatment plan acquired from the network hospital platform;
  • the comparison and statistics module 20 is configured to compare the blood glucose value of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and count the comparison result in the preset monitoring period;
  • the plan sending module 30 is configured to determine a blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and send a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to perform the blood sugar adjusting plan.
  • the primary medical platform proposed by the embodiments of the present invention may be a medical institution installed in a township, a village, or the like, or may be a medical institution such as a social health clinic or a clinic set in a community or a community, and the primary medical platform collects the locality or The basic information of all residents of the community or community and the medical information such as the medical history of the resident are monitored by the primary medical platform for chronically ill patients under its jurisdiction.
  • a method for monitoring a diabetic person by a primary medical platform is taken as an example for description.
  • the blood glucose monitoring module 10 of the primary medical platform obtains the user's medical treatment plan corresponding to the user from the network hospital platform, and the user medical treatment plan is a medical treatment intervention plan formed for each diabetic person stored in the database of the network hospital platform, and the medical treatment plan can be It includes the diagnosis result of the user's visit to the hospital, the monitoring period of blood glucose monitoring for the user, the collection time of the blood glucose collected during the monitoring period, and the blood glucose adjustment for all possible conditions of the user's blood sugar level. plan.
  • the primary medical platform monitors the blood glucose level of the user within a monitoring period according to a preset monitoring period in the user's medical treatment plan, for example, monitoring the blood glucose level of the user within one week or 10 days, and the preset time is specifically referred to as corresponding The user's blood glucose monitoring time point.
  • the primary medical platform After monitoring the blood glucose level of the user at the preset time, the primary medical platform matches the blood glucose threshold of the corresponding time in the user's medical treatment plan, and the comparison and statistics module 20 performs the blood glucose level of the preset time and the blood glucose threshold corresponding to the time. Contrast to determine if the user's blood glucose level at this time is too high or too low.
  • the comparison and statistics module 20 also counts the blood glucose value comparison results within a preset monitoring period to analyze the blood glucose monitoring results during the monitoring period after the monitoring period ends.
  • the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the monitoring period, that is, according to the blood glucose level of the user at the preset time within a preset monitoring period. Continuous monitoring to determine if the blood glucose level during the monitoring period is stable, whether it continues to be above the blood glucose threshold, or continues below the blood glucose threshold.
  • the blood glucose monitoring result is determined, and the primary medical platform performs matching in the user diagnosis plan according to the situation corresponding to the blood glucose monitoring result, and matches the blood glucose adjustment plan corresponding to the blood glucose monitoring result, and the plan sending module 30 sends the blood glucose adjustment plan to the user for the user to follow.
  • the content of the blood glucose adjustment plan is implemented to achieve basic monitoring of the user's blood glucose level and monitoring of the implementation of the treatment plan.
  • the blood glucose adjustment plan includes at least one of a drug treatment plan, a diet plan, an exercise program, and a treatment cycle.
  • the embodiment of the invention acquires the user diagnosis and treatment plan from the network hospital platform through the primary medical platform, and monitors the blood glucose value of the user at the preset time in the preset monitoring period, and corresponds the blood glucose value of the user at the preset time to the user diagnosis plan.
  • the blood glucose threshold of the time is compared, and the comparison result in the preset monitoring period is counted, the blood glucose monitoring result in the monitoring period is determined according to the comparison result in the monitoring period, and the blood glucose adjusting plan corresponding to the blood glucose monitoring result is sent to the user, Allows the user to perform a blood glucose adjustment program.
  • relevant parameters monitoring, reminding and intervention intervention for diabetic patients are carried out according to the user's medical treatment plan, thereby improving the treatment progress and treatment effect for diabetic patients.
  • the blood glucose monitoring module 10 is specifically configured to: Sending an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan during the preset monitoring period;
  • the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device are received, and the fasting blood glucose value and the postprandial blood glucose value are analyzed and managed within a preset monitoring period.
  • the blood glucose monitoring module 10 sends an acquisition instruction to the monitoring device for collecting the user's blood sugar level according to the preset monitoring time of each day in the preset monitoring period, and monitors The device collects the fasting blood glucose value and the postprandial blood glucose value of the user, and specifically collects the fasting blood glucose value of the user before the meal in the morning and the postprandial blood glucose value after two hours of eating the breakfast, and the fasting blood glucose value of the user that the monitoring device will collect. And postprandial blood glucose values are sent to the primary care platform.
  • the blood glucose monitoring module 10 records the fasting blood glucose level and the postprandial blood glucose value of the user every day in the monitoring period; and compares each fasting blood glucose value and the postprandial blood glucose value with the blood glucose threshold, and records each time in the monitoring period. The results are compared to determine the blood glucose monitoring results during the monitoring period based on the statistical results of the comparison results within one monitoring period.
  • the plan sending module 30 is specifically configured to: During a preset monitoring period, such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high When the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, determining corresponding conditions Blood glucose monitoring results;
  • the blood glucose adjustment plan corresponding to the determined blood glucose monitoring result is matched in the user treatment plan, and the matched blood sugar adjustment plan is sent to the user for the user to perform the blood sugar adjustment plan.
  • the primary medical platform determines the blood glucose monitoring result during the monitoring period according to the comparison result in the preset monitoring period, specifically, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold value during the entire monitoring period, and / or the postprandial blood glucose level is continuously higher or lower than the postprandial blood glucose threshold, it can be determined that the blood glucose monitoring result for the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold; or, such as fasting blood glucose
  • the value of the value above or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, and may also be determined
  • the blood glucose monitoring result of the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold, and the preset number of times can be set according to the number of days of the monitoring period.
  • the preset number of times may be 4 times, that is to say, during the monitoring period of one week, if the number of times the blood glucose level is higher or lower than the blood glucose threshold is greater than 4 times, the blood of the user during the monitoring period can be considered.
  • the result of sugar monitoring is that the blood glucose level continues to be above or below the blood glucose threshold.
  • the primary medical platform only needs to record the user's fasting blood glucose level and/or postprandial blood glucose value and blood glucose monitoring result, and can also send a prompt message to the user that the blood glucose monitoring result is stable blood sugar level, and The user's blood glucose level at the preset time is continuously monitored during the next monitoring cycle.
  • the blood glucose monitoring result is determined for the user during the monitoring period, and the primary medical platform matches the determined blood glucose monitoring plan corresponding to the determined blood glucose monitoring result in the user medical treatment plan.
  • the user's medical treatment plan stores the blood sugar level for the user.
  • the blood glucose adjustment plan of all the cases that may occur after determining the blood glucose monitoring result of the user, the primary medical platform matches the blood glucose adjustment plan corresponding to the corresponding blood glucose monitoring result in the user diagnosis plan, and the blood sugar adjustment plan is planned by the plan sending module 30.
  • the method is sent to the user, and can be sent to the user's smart terminal or the monitoring device for collecting the user's blood sugar level by text, voice or video, etc., to remind the user to perform treatment according to each scheme in the blood sugar adjustment plan.
  • the primary medical platform uploads the blood glucose monitoring result to the network hospital platform through the plan sending module 30 for the network hospital platform side.
  • the doctor performs analysis and diagnosis and adjusts or regenerates the blood glucose adjustment plan based on the results of the analysis and diagnosis.
  • FIG. 7 is a schematic structural view of a second embodiment of a primary medical platform according to the present invention.
  • the primary medical platform further includes:
  • the obtaining module 40 is configured to connect to the network hospital platform, and obtain a user medical treatment plan corresponding to the user according to related information of the user.
  • the primary health care platform Before the primary health care platform monitors the diabetics under its jurisdiction, it first connects to the network hospital platform through the acquisition module 40. Specifically, it can request to connect to the network hospital platform by inputting the login account and login password, and verifying the network hospital platform. After that, the user's medical treatment plan corresponding to the user can be obtained in the network hospital according to the relevant information of the user that needs to be obtained.
  • the related information of the user may include basic information such as the user's name, gender, or the unique registered number of the user on the network hospital platform, or the location of the user, or the living information of the community or the community, and the primary medical platform according to the related information. Obtaining a user diagnosis plan corresponding to the user from the network hospital platform to perform blood glucose monitoring on the user.
  • FIG. 8 is a schematic structural view of a third embodiment of a primary medical platform according to the present invention.
  • the primary medical platform further includes:
  • the marking and storage module 50 is configured to mark and store the blood glucose value of the preset time above or below the blood glucose threshold.
  • the marking and storage module 50 After receiving the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and comparing with the corresponding blood glucose threshold, if the blood glucose value is higher or lower than the blood glucose threshold of the corresponding time, the marking and storage module 50 is passed.
  • the blood glucose value is marked and stored. Specifically, the blood glucose value can be marked by color marking or highlighting, and stored for later time to clearly reflect the time corresponding to the abnormal blood sugar value of the user. And the size of the blood sugar level.
  • it can also be transmitted to the network hospital platform for the doctors on the network hospital platform side to perform relevant statistics and marking.

Abstract

Disclosed is a diabetes patient monitoring method based on a primary-level medical platform. The method comprises: a primary-level medical platform monitors, according to a user diagnosis and treatment plan acquired from a network hospital platform, a blood glucose value of a user in a preset time within a preset monitoring period; the primary-level medical platform compares the blood glucose value of the user in the preset time with a blood glucose threshold value in a corresponding time in the user diagnosis and treatment plan, and makes statistics on comparison results within the preset monitoring period; and the primary-level medical platform determines, according to the comparison results within the preset monitoring period, a blood glucose monitoring result within the monitoring period, and sends a blood glucose regulating plan corresponding to the blood glucose monitoring result to the user, thus enabling the user to execute the blood glucose regulating plan. Also disclosed is a primary-level medical platform. Through connection of a primary-level medical platform and a network hospital platform, relevant parameter monitoring, reminding and execution intervention can be performed on a diabetes patient according to a user diagnosis and treatment plan, thereby increasing the treatment progress and the treatment effect of the diabetes patient.

Description

基层医疗平台以及基于基层医疗平台的糖尿病人监控方法  Primary medical platform and monitoring method for diabetics based on primary medical platform
技术领域Technical field
本发明涉及医疗技术领域,尤其涉及一种基层医疗平台以及基于基层医疗平台的糖尿病人监控方法。The present invention relates to the field of medical technology, and in particular, to a primary medical platform and a monitoring method for a diabetic based on a primary medical platform.
背景技术Background technique
对于糖尿病、高血压和心脏病等慢性病患者,由于血糖、血压和心电监测是需要长期执行的,通常情况下,患者在一次去医院就诊后,医生会针对该患者开出相应的诊疗计划,而对于处于偏远地区或不方便去医院做定期检测的患者来说,医院对其对诊疗计划的执行情况相当难监控,往往是再次出现异常时才去医院,如情况较严重则会耽误救治,导致难以挽回的结果。目前,由于医院的性质以及医生和医疗资源的局限性,对于慢性病患者的监控很难做到面面俱到,无法对患者对诊疗计划的执行情况进行全面的干预和提醒,这在很大程度上降低了对慢性病患者的治疗进度和治疗效果。For patients with chronic diseases such as diabetes, high blood pressure and heart disease, blood glucose, blood pressure and ECG monitoring need to be implemented for a long time. Usually, after a patient visits the hospital, the doctor will open a corresponding treatment plan for the patient. For patients who are in remote areas or who are not convenient to go to the hospital for regular testing, it is very difficult for the hospital to monitor the implementation of the treatment plan. It is often when the abnormality occurs again before going to the hospital. If the situation is serious, the treatment will be delayed. Lead to irreversible results. At present, due to the nature of the hospital and the limitations of doctors and medical resources, it is difficult to monitor the chronic disease patients, and it is impossible to comprehensively intervene and remind the patient about the implementation of the treatment plan, which is greatly reduced. Treatment progress and treatment effects for patients with chronic diseases.
发明内容Summary of the invention
本发明的主要目的在于提供一种基层医疗平台以及基于基层医疗平台的糖尿病人监控方法,能够对糖尿病患者对诊疗计划的执行情况进行全面的干预和提醒,从而提高对糖尿病患者的治疗进度和治疗效果。The main objective of the present invention is to provide a primary medical platform and a monitoring method for a diabetic based on a primary medical platform, which can comprehensively intervene and remind the implementation of the diagnosis and treatment plan for the diabetic patient, thereby improving the treatment progress and treatment for the diabetic patient. effect.
为实现上述目的,本发明提供了一种基于基层医疗平台的糖尿病人监控方法,所述监控方法包括以下步骤:To achieve the above object, the present invention provides a method for monitoring a diabetic person based on a primary medical platform, the monitoring method comprising the following steps:
基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值;The primary medical platform monitors the user's blood glucose level at a preset time in a preset monitoring period according to the user medical treatment plan obtained from the network hospital platform;
基层医疗平台将用户在预设时间的血糖值与所述用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果;The primary medical platform compares the blood glucose level of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and counts the comparison result within the preset monitoring period;
基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送所述血糖监控结果对应的血糖调整计划,供用户执行所述血糖调整计划。The primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to execute the blood sugar adjusting plan.
优选地,所述基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值的步骤具体包括:Preferably, the step of monitoring, by the primary medical platform, the blood glucose level of the user at the preset time in the preset monitoring period according to the user medical treatment plan acquired from the network hospital platform comprises:
基层医疗平台在预设的监控周期内,根据用户诊疗计划中的监测时间,发送采集指令至监测设备;The primary medical platform sends an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan within a preset monitoring period;
基层医疗平台接收监测设备发送的用户的空腹血糖值和餐后血糖值,并在预设的监控周期内对所述空腹血糖值和餐后血糖值进行分析和管理。The primary medical platform receives the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzes and manages the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
优选地,所述基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送所述血糖监控结果对应的血糖调整计划,供用户执行所述血糖调整计划的步骤具体包括:Preferably, the primary medical platform determines a blood glucose monitoring result in the monitoring period according to a comparison result in a preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user, where the user performs the blood glucose adjustment The steps of the plan specifically include:
在预设的监控周期内,如空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值时,或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值时,基层医疗平台确定不同情况所对应的血糖监控结果;During a preset monitoring period, such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high The primary medical platform determines different conditions when the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of postprandial blood glucose values above or below the postprandial blood glucose threshold is greater than a preset number of thresholds Corresponding blood glucose monitoring results;
基层医疗平台在所述用户诊疗计划中匹配确定的所述血糖监控结果对应的血糖调整计划,并将匹配的所述血糖调整计划发送至用户,以供用户执行所述血糖调整计划。The primary medical platform matches the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user treatment plan, and sends the matched blood glucose adjustment plan to the user for the user to execute the blood sugar adjustment plan.
优选地,所述基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值的步骤之前,所述监控方法还包括:Preferably, the monitoring method further includes: before the step of monitoring the blood glucose level of the user at the preset time in the preset monitoring period, according to the user medical treatment plan acquired from the network hospital platform, the monitoring method further includes:
基层医疗平台与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The primary medical platform is connected with the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the relevant information of the user.
优选地,所述当预设时间的血糖值超出对应时间的血糖值阈值时,基层医疗平台向用户发送血糖调整计划,供用户执行所述血糖调整计划的步骤之后,所述监控方法还包括步骤:Preferably, when the blood glucose level of the preset time exceeds the blood glucose threshold of the corresponding time, the primary medical platform sends the blood glucose adjustment plan to the user, after the step of the user performing the blood glucose adjustment plan, the monitoring method further includes the step :
基层医疗平台对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。The primary care platform marks and stores the blood glucose values for a preset time above or below the blood glucose threshold.
此外,本发明还提供一种用于糖尿病人监控方法的基层医疗平台,所述基层医疗平台包括:In addition, the present invention also provides a primary medical platform for a diabetes monitoring method, the primary medical platform comprising:
血糖监控模块,用于根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值;The blood glucose monitoring module is configured to monitor a blood glucose value of the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform;
对比及统计模块,用于将用户在预设时间的血糖值与所述用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果;The comparison and statistics module is configured to compare the blood glucose value of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and compare the comparison result in the preset monitoring period;
计划发送模块,用于根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送所述血糖监控结果对应的血糖调整计划,供用户执行所述血糖调整计划。The plan sending module is configured to determine a blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and send a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user, where the user performs the blood sugar adjusting plan.
优选地,所述血糖监控模块具体用于:Preferably, the blood glucose monitoring module is specifically configured to:
在预设的监控周期内,根据用户诊疗计划中的监测时间,发送采集指令至监测设备;Sending an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan during the preset monitoring period;
接收监测设备发送的用户的空腹血糖值和餐后血糖值,并在预设的监控周期内对所述空腹血糖值和餐后血糖值进行分析和管理。Receiving the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzing and managing the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
优选地,所述计划发送模块具体用于:Preferably, the plan sending module is specifically configured to:
在预设的监控周期内,如空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值时,或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值时,确定不同情况所对应的血糖监控结果;During a preset monitoring period, such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high When the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, determining corresponding conditions Blood glucose monitoring results;
在所述用户诊疗计划中匹配确定的所述血糖监控结果对应的血糖调整计划,并将匹配的所述血糖调整计划发送至用户,以供用户执行所述血糖调整计划。Matching the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user treatment plan, and transmitting the matched blood sugar adjustment plan to the user for the user to execute the blood sugar adjustment plan.
优选地,所述基层医疗平台还包括:Preferably, the primary medical platform further comprises:
获取模块,用于与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The obtaining module is configured to connect with the network hospital platform, and obtain the user medical treatment plan corresponding to the user according to the related information of the user.
优选地,所述基层医疗平台还包括:Preferably, the primary medical platform further comprises:
标记及存储模块,用于对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。A marking and storage module for marking and storing blood glucose values for a preset time above or below a blood glucose threshold.
本发明通过基层医疗平台从网络医院平台获取用户诊疗计划,并在预设的监控周期内监测用户在预设时间的血糖值,将用户在预设时间的血糖值与用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果,根据该监控周期内的对比结果确定该监控周期内的血糖监控结果,向用户发送血糖监控结果对应的血糖调整计划,供用户执行血糖调整计划。通过基层医疗平台与网络医院平台的对接,根据用户诊疗计划对糖尿病患者进行相关的参数监测、提醒和执行干预,从而提高了对糖尿病患者的治疗进度和治疗效果。The invention acquires a user diagnosis and treatment plan from the network hospital platform through the primary medical platform, and monitors the blood sugar value of the user at a preset time in a preset monitoring period, and compares the blood glucose value of the user at the preset time with the corresponding time in the user diagnosis plan. The blood glucose threshold is compared, and the comparison result in the preset monitoring period is counted, the blood glucose monitoring result in the monitoring period is determined according to the comparison result in the monitoring period, and the blood glucose adjusting plan corresponding to the blood glucose monitoring result is sent to the user for the user Perform a blood glucose adjustment program. Through the docking of the primary medical platform and the network hospital platform, relevant parameters monitoring, reminding and intervention intervention for diabetic patients are carried out according to the user's medical treatment plan, thereby improving the treatment progress and treatment effect for diabetic patients.
附图说明DRAWINGS
图1为本发明基于基层医疗平台的糖尿病人监控方法第一实施例的流程示意图;1 is a schematic flow chart of a first embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention;
图2为图1中步骤S10的细化流程示意图;2 is a schematic diagram of a refinement process of step S10 in FIG. 1;
图3为图1中步骤S30的细化流程示意图;3 is a schematic diagram of a refinement process of step S30 in FIG. 1;
图4为本发明基于基层医疗平台的糖尿病人监控方法第二实施例的流程示意图;4 is a schematic flow chart of a second embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention;
图5为本发明基于基层医疗平台的糖尿病人监控方法第三实施例的流程示意图;5 is a schematic flow chart of a third embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention;
图6为本发明基层医疗平台第一实施例的结构示意图;6 is a schematic structural view of a first embodiment of a primary medical platform according to the present invention;
图7为本发明基层医疗平台第二实施例的结构示意图;7 is a schematic structural view of a second embodiment of a primary medical platform according to the present invention;
图8为本发明基层医疗平台第三实施例的结构示意图。FIG. 8 is a schematic structural view of a third embodiment of a primary medical platform according to the present invention.
本发明目的的实现、功能特点及优点将结合实施例,参照附图做进一步说明。The implementation, functional features, and advantages of the present invention will be further described in conjunction with the embodiments.
具体实施方式detailed description
应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。It is understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
本发明提供的糖尿病人监控方法,通过基层医疗平台与网络医院平台的对接,获取糖尿病患者对应的用户诊疗计划,并根据用户诊疗计划对糖尿病患者进行相关的参数监测、提醒和执行干预,以提高对糖尿病患者的治疗进度和治疗效果。The monitoring method for diabetics provided by the invention obtains the corresponding user diagnosis and treatment plan of the diabetic patient through the docking of the primary medical platform and the network hospital platform, and performs related parameter monitoring, reminding and performing intervention on the diabetes patient according to the user diagnosis and treatment plan to improve Treatment progress and treatment effects for diabetic patients.
参照图1,图1为本发明基于基层医疗平台的糖尿病人监控方法第一实施例的流程示意图。Referring to FIG. 1, FIG. 1 is a schematic flowchart diagram of a first embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention.
在本发明第一实施例中,基于基层医疗平台的糖尿病人监控方法包括:In the first embodiment of the present invention, the diabetes monitoring method based on the primary medical platform includes:
步骤S10,基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值;Step S10: The primary medical platform monitors the blood glucose level of the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform;
本发明实施例所提出的基层医疗平台,可以是设置在乡镇、村等地的医疗机构,也可以是设置在社区或小区的社康、诊所等医疗机构,基层医疗平台中收集了该地或者该社区或小区的所有居民的基本信息以及该居民的病史等医疗信息,通过基层医疗平台对其所管辖的慢性病病人进行监控。本实施例中以基层医疗平台对糖尿病人监控的方法为例进行说明。The primary medical platform proposed by the embodiments of the present invention may be a medical institution installed in a township, a village, or the like, or may be a medical institution such as a social health clinic or a clinic set in a community or a community, and the primary medical platform collects the locality or The basic information of all residents of the community or community and the medical information such as the medical history of the resident are monitored by the primary medical platform for chronically ill patients under its jurisdiction. In this embodiment, a method for monitoring a diabetic person by a primary medical platform is taken as an example for description.
基层医疗平台从网络医院平台获取用户对应的用户诊疗计划,该用户诊疗计划是在网络医院平台的数据库中存储的针对每个糖尿病人所形成的诊疗干预计划,诊疗计划中可包括用户在医院就诊时的确诊结果、对该用户进行血糖监控的监控周期和在该监控周期内所需采集血糖值的采集时间,以及针对用户的血糖值可能出现的所有情况而制定的血糖调整计划。基层医疗平台根据该用户诊疗计划中所预设的监控周期,例如监控一周内或10天内用户的血糖值,在该监控周期内对预设时间的血糖值进行监测,预设时间具体指为相应的用户所制定的血糖监测时间点。The primary medical platform obtains the user's corresponding medical treatment plan from the network hospital platform, and the user medical treatment plan is a medical treatment intervention plan formed for each diabetic person stored in the database of the network hospital platform, and the medical treatment plan may include the user visiting the hospital. The time of diagnosis, the monitoring period for blood glucose monitoring of the user, the time of collection of blood glucose values required during the monitoring period, and the blood glucose adjustment plan for all possible conditions of the user's blood glucose level. The primary medical platform monitors the blood glucose level of the user within a monitoring period according to a preset monitoring period in the user's medical treatment plan, for example, monitoring the blood glucose level of the user within one week or 10 days, and the preset time is specifically referred to as corresponding The user's blood glucose monitoring time point.
步骤S20,基层医疗平台将用户在预设时间的血糖值与用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果;Step S20: The primary medical platform compares the blood glucose level of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and counts the comparison result within the preset monitoring period;
监测到用户在预设时间的血糖值后,基层医疗平台在用户诊疗计划中匹配对应时间的血糖值阈值,并将预设时间的血糖值与该时间对应的血糖值阈值进行对比,以确定用户在该时间的血糖值过高还是过低。基层医疗平台还统计在预设的监控周期内的血糖值对比结果,以在该监控周期结束后分析该监控周期内的血糖监控结果。After monitoring the blood glucose level of the user at the preset time, the primary medical platform matches the blood glucose threshold of the corresponding time in the user diagnosis plan, and compares the blood glucose value of the preset time with the blood glucose threshold corresponding to the time to determine the user. The blood glucose level at this time is too high or too low. The primary care platform also counts the blood glucose comparison results within a preset monitoring period to analyze the blood glucose monitoring results during the monitoring period after the monitoring period ends.
步骤S30,基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送血糖监控结果对应的血糖调整计划,供用户执行血糖调整计划。In step S30, the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to perform the blood sugar adjusting plan.
在一个监控周期结束后,基层医疗平台根据在该监控周期内的对比结果,确定该监控周期内的血糖监控结果,即根据在一个预设的监控周期内对用户在预设时间的血糖值的持续监控,确定在该监控周期内的血糖值是否稳定,是否持续高于血糖值阈值,或者持续低于血糖值阈值。确定了血糖监控结果,基层医疗平台根据血糖监控结果对应的情况,在用户诊疗计划中进行匹配,匹配出该血糖监控结果对应的血糖调整计划,将其发送至用户,供用户按照血糖调整计划中的内容执行,以实现对用户的血糖值的基础监控以及对诊疗计划的执行情况的监控。本实施例中,血糖调整计划包括药物治疗方案、饮食方案、运动方案以及治疗周期中的至少一项,用户可根据血糖调整计划的指导通过药物的方法进行治疗,同时以饮食方案和运动方案作为辅助,在治疗周期内执行该血糖调整计划中的内容。After the end of a monitoring period, the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the monitoring period, that is, according to the blood glucose level of the user at the preset time within a preset monitoring period. Continuous monitoring to determine if the blood glucose level during the monitoring period is stable, whether it continues to be above the blood glucose threshold, or continues below the blood glucose threshold. The blood glucose monitoring result is determined, and the primary medical platform matches the user's medical treatment plan according to the corresponding situation of the blood glucose monitoring result, matches the blood glucose adjustment plan corresponding to the blood glucose monitoring result, and sends it to the user for the user to follow the blood sugar adjustment plan. The content is executed to achieve basic monitoring of the user's blood glucose level and monitoring of the implementation of the treatment plan. In this embodiment, the blood glucose adjustment plan includes at least one of a drug treatment plan, a diet plan, an exercise plan, and a treatment cycle, and the user can perform the drug treatment according to the guidance of the blood sugar adjustment plan, and adopts the diet plan and the exercise plan as the diet plan and the exercise plan. Auxiliary, the content of the blood glucose adjustment plan is executed during the treatment cycle.
本发明实施例通过基层医疗平台从网络医院平台获取用户诊疗计划,并在预设的监控周期内监测用户在预设时间的血糖值,将用户在预设时间的血糖值与用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果,根据该监控周期内的对比结果确定该监控周期内的血糖监控结果,向用户发送血糖监控结果对应的血糖调整计划,供用户执行血糖调整计划。通过基层医疗平台与网络医院平台的对接,根据用户诊疗计划对糖尿病患者进行相关的参数监测、提醒和执行干预,从而提高了对糖尿病患者的治疗进度和治疗效果。The embodiment of the invention acquires the user diagnosis and treatment plan from the network hospital platform through the primary medical platform, and monitors the blood glucose value of the user at the preset time in the preset monitoring period, and corresponds the blood glucose value of the user at the preset time to the user diagnosis plan. The blood glucose threshold of the time is compared, and the comparison result in the preset monitoring period is counted, the blood glucose monitoring result in the monitoring period is determined according to the comparison result in the monitoring period, and the blood glucose adjusting plan corresponding to the blood glucose monitoring result is sent to the user, Allows the user to perform a blood glucose adjustment program. Through the docking of the primary medical platform and the network hospital platform, relevant parameters monitoring, reminding and intervention intervention for diabetic patients are carried out according to the user's medical treatment plan, thereby improving the treatment progress and treatment effect for diabetic patients.
参照图2,图2为图1中步骤S10的细化流程示意图。在上述实施例中,步骤S10具体包括: 步骤S101,基层医疗平台在预设的监控周期内,根据用户诊疗计划中的监测时间,发送采集指令至监测设备; 步骤S102,基层医疗平台接收监测设备发送的用户的空腹血糖值和餐后血糖值,并在预设的监控周期内对空腹血糖值和餐后血糖值进行分析和管理。Referring to FIG. 2, FIG. 2 is a schematic diagram of the refinement process of step S10 in FIG. In the above embodiment, step S10 specifically includes: Step S101: The primary medical platform sends an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan within a preset monitoring period; Step S102: The primary medical platform receives the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzes and manages the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
基层医疗平台获取用户的用户诊疗计划后,在其中所预设的监控周期内,根据预设的每一天的监测时间,向用于采集用户血糖值的监测设备发送采集指令,该监测设备为具有通讯功能的血糖仪,可与基层医疗平台进行通讯连接,接收基层医疗平台发送的采集指令,并向基层医疗平台反馈所测得的用户的血糖值。监测设备采集用户的空腹血糖值和餐后血糖值,具体可优选采集用户在早晨进餐前的空腹血糖值和进食早餐两个小时后的餐后血糖值,因为这两个时间点的血糖值更能准确反映用户的血糖情况,监测设备将采集到的用户的空腹血糖值和餐后血糖值发送至基层医疗平台。基层医疗平台以监控周期为单位,记录用户每天的空腹血糖值和餐后血糖值;并且对比每一次空腹血糖值和餐后血糖值与对应时间的血糖值阈值,同时以监控周期为单位记录每次的对比结果,以根据对一个监控周期内的对比结果的统计情况,确定该监控周期内的血糖监控结果。After obtaining the user's medical treatment plan of the user, the primary medical platform sends an acquisition instruction to the monitoring device for collecting the blood sugar level of the user according to the preset monitoring time of each day in the preset monitoring period, and the monitoring device has The communication function blood glucose meter can communicate with the primary medical platform, receive the acquisition instruction sent by the primary medical platform, and feed back the measured blood sugar value of the user to the primary medical platform. The monitoring device collects the fasting blood sugar value and the postprandial blood sugar value of the user, and specifically, it is preferable to collect the fasting blood sugar value of the user before the meal in the morning and the postprandial blood sugar value after eating the breakfast for two hours, because the blood sugar values at the two time points are more It can accurately reflect the user's blood sugar condition, and the monitoring device will send the collected fasting blood glucose value and postprandial blood glucose value to the primary medical platform. The primary medical platform records the daily fasting blood glucose level and postprandial blood glucose value of the user in the monitoring period; and compares the fasting blood glucose level and the postprandial blood glucose value with the corresponding blood glucose threshold, and records each in the monitoring period. The results of the comparison are based on the statistical analysis of the comparison results within a monitoring period to determine the blood glucose monitoring results during the monitoring period.
参照图3,图3为图1中步骤S30的细化流程示意图。 在上述实施例中,步骤S30具体包括: 步骤S301,在预设的监控周期内,如空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值时,或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值时,基层医疗平台确定不同情况所对应的血糖监控结果;Referring to FIG. 3, FIG. 3 is a schematic diagram of the refinement process of step S30 in FIG. In the above embodiment, step S30 specifically includes: Step S301, in a preset monitoring period, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold, and/or the postprandial blood glucose value is continuously higher or lower than the postprandial blood glucose threshold, or, such as, fasting The primary medical platform when the blood glucose level is higher or lower than the fasting blood glucose threshold than the preset threshold, and/or the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than the preset threshold Determine the blood glucose monitoring results corresponding to different situations;
基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果时,具体地,如在整个监控周期内,空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值,则可确定在该监控周期内对用户的血糖监控结果为血糖值持续高于或低于血糖值阈值;或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值,也可确定在该监控周期内对用户的血糖监控结果为血糖值持续高于或低于血糖值阈值,预设的次数可按照监控周期的天数进行相应设置,例如,监控周期为一周,则预设的次数可为4次,也就是说,在一周的监控周期内,如血糖值高于或低于血糖值阈值的次数大于4次,则可认为在该监控周期内对用户的血糖监控结果为血糖值持续高于或低于血糖值阈值。The primary medical platform determines the blood glucose monitoring result during the monitoring period according to the comparison result in the preset monitoring period, specifically, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold value during the entire monitoring period, and / or the postprandial blood glucose level is continuously higher or lower than the postprandial blood glucose threshold, it can be determined that the blood glucose monitoring result for the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold; or, such as fasting blood glucose The value of the value above or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, and may also be determined The blood glucose monitoring result of the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold, and the preset number of times can be set according to the number of days of the monitoring period. For example, if the monitoring period is one week, the preset number of times may be 4 times, that is to say, during the monitoring period of one week, if the number of times the blood glucose level is higher or lower than the blood glucose threshold is greater than 4 times, the blood of the user during the monitoring period can be considered. The result of sugar monitoring is that the blood glucose level continues to be above or below the blood glucose threshold.
此外,如在整个监控周期内,用户的空腹血糖值和/或餐后血糖值保持稳定,并未高于或低于血糖值阈值,则可确定在该监控周期内对用户的血糖监控结果为血糖值稳定,在这种情况下,基层医疗平台只需记录用户的空腹血糖值和/或餐后血糖值以及血糖监控结果,当然,也可向用户发送血糖监控结果为血糖值稳定的提示消息,并在下一个监控周期继续监控用户在预设时间的血糖值,以实现对糖尿病患者的长期监控和干预。In addition, if the user's fasting blood glucose level and/or postprandial blood glucose level remain stable throughout the monitoring period and are not above or below the blood glucose threshold, it may be determined that the blood glucose monitoring result for the user during the monitoring period is The blood glucose level is stable. In this case, the primary medical platform only needs to record the user's fasting blood glucose level and/or postprandial blood glucose value and blood glucose monitoring result. Of course, the user can also send the blood glucose monitoring result to the blood glucose value stable prompt message. And continue to monitor the user's blood glucose level at the preset time in the next monitoring cycle to achieve long-term monitoring and intervention for diabetic patients.
步骤S302,基层医疗平台在用户诊疗计划中匹配确定的血糖监控结果对应的血糖调整计划,并将匹配的血糖调整计划发送至用户,以供用户执行血糖调整计划。 确定了在监控周期内对用户的血糖监控结果,基层医疗平台在用户诊疗计划中匹配所确定的血糖监控结果对应的血糖调整计划,匹配时,由于用户诊疗计划中存储有针对该用户的血糖值可能出现的所有情况的血糖调整计划,确定了用户的血糖监控结果后,基层医疗平台在用户诊疗计划中匹配相应的血糖监控结果所对应的血糖调整计划,将该血糖调整计划发送至用户,具体可以文字、语音或视频等方式发送至用户的智能终端或用于采集用户血糖值的监测设备,以提醒用户按照血糖调整计划中的各方案进行治疗。Step S302, the primary medical platform matches the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user diagnosis plan, and sends the matched blood sugar adjustment plan to the user for the user to perform the blood sugar adjustment plan. The blood glucose monitoring result is determined for the user during the monitoring period, and the primary medical platform matches the determined blood glucose monitoring plan corresponding to the determined blood glucose monitoring result in the user medical treatment plan. When matching, the user's medical treatment plan stores the blood sugar level for the user. The blood glucose adjustment plan of all the cases that may occur, after determining the blood glucose monitoring result of the user, the primary medical platform matches the blood glucose adjustment plan corresponding to the corresponding blood glucose monitoring result in the user medical treatment plan, and sends the blood sugar adjustment plan to the user, specifically It can be sent to the user's smart terminal or monitoring device for collecting the user's blood sugar value by text, voice or video to remind the user to follow the various schemes in the blood glucose adjustment plan.
本实施例中,如用户的血糖监控结果是血糖值持续高于或低于血糖值阈值,则基层医疗平台将该血糖监控结果上传至网络医院平台,供网络医院平台侧的医生进行分析和诊断,并根据分析和诊断的结果调整或重新生成血糖调整计划。In this embodiment, if the blood glucose monitoring result of the user is that the blood glucose level is continuously higher or lower than the blood glucose threshold, the primary medical platform uploads the blood glucose monitoring result to the network hospital platform for analysis and diagnosis by the doctor on the network hospital platform side. And adjust or regenerate the glycemic adjustment plan based on the results of the analysis and diagnosis.
参照图4,图4为本发明基于基层医疗平台的糖尿病人监控方法第二实施例的流程示意图。 基于本发明第一实施例,第二实施例中,在执行上述步骤S10之前,该监控方法还包括: 步骤S40,基层医疗平台与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。Referring to FIG. 4, FIG. 4 is a schematic flowchart diagram of a second embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention. According to the first embodiment of the present invention, in the second embodiment, before the step S10 is performed, the monitoring method further includes: In step S40, the primary medical platform is connected to the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the related information of the user.
基层医疗平台在对其所管辖的糖尿病人进行监控前,首先与网络医院平台连接,具体可通过输入登陆账号和登陆密码的方式请求连接至网络医院平台,在网络医院平台验证通过后,可根据所需获取的用户的相关信息,在网络医院中获取该用户对应的用户诊疗计划。用户的相关信息可包括用户的姓名、性别等基本信息,或者该用户在网络医院平台的唯一的挂号号码,或者包括用户所属地,或者所属社区或小区的居住信息,基层医疗平台根据这些相关信息,从网络医院平台获取对应于该用户的用户诊疗计划,以对该用户进行血糖监控。Before the primary health care platform monitors the diabetics under its jurisdiction, it first connects to the network hospital platform. Specifically, it can be connected to the network hospital platform by entering the login account and login password. After the network hospital platform is verified, it can be based on The user-related information of the user to be obtained is obtained in the network hospital. The related information of the user may include basic information such as the user's name, gender, or the unique registered number of the user on the network hospital platform, or the location of the user, or the living information of the community or the community, and the primary medical platform according to the related information. Obtaining a user diagnosis plan corresponding to the user from the network hospital platform to perform blood glucose monitoring on the user.
参照图5,图5为本发明基于基层医疗平台的糖尿病人监控方法第三实施例的流程示意图。 基于本发明第一实施例,第三实施例中,在执行上述步骤S30之后,该监控方法还包括: 步骤S50,基层医疗平台对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。Referring to FIG. 5, FIG. 5 is a schematic flowchart diagram of a third embodiment of a method for monitoring a diabetic person based on a primary medical platform according to the present invention. Based on the first embodiment of the present invention, in the third embodiment, after performing the foregoing step S30, the monitoring method further includes: In step S50, the primary medical platform marks and stores the blood glucose value of the preset time above or below the blood glucose threshold.
接收到监测设备发送的用户的空腹血糖值和餐后血糖值,并与相应的血糖值阈值进行对比后,如血糖值高于或低于对应时间的血糖值阈值,则将该血糖值进行标记并存储,具体地,可通过颜色标记或突出显示的方式标记血糖值,并将其存储,以供日后查看时可清楚明了的反映出用户出现异常的血糖值对应的时间和血糖值的大小。本实施例中,针对每次所监测到的高于或低于血糖值阈值的血糖值,也可将其传输至网络医院平台,供网络医院平台侧的医生进行相关的统计和标记。Receiving the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and comparing with the corresponding blood glucose threshold, if the blood glucose value is higher or lower than the blood glucose threshold of the corresponding time, the blood glucose value is marked And storing, in particular, the blood glucose value can be marked by color marking or highlighting, and stored for later clearing to reflect the time and blood sugar level corresponding to the abnormal blood sugar value of the user. In this embodiment, for each monitored blood glucose level above or below the blood glucose threshold, it can also be transmitted to the network hospital platform for the doctors on the network hospital platform side to perform relevant statistics and marking.
本发明还提供一种基层医疗平台。 参照图6,图6为本发明基层医疗平台第一实施例的结构示意图。 在本发明第一实施例中,基层医疗平台包括: 血糖监控模块10,用于根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值; 对比及统计模块20,用于将用户在预设时间的血糖值与用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果; 计划发送模块30,用于根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送血糖监控结果对应的血糖调整计划,供用户执行血糖调整计划。The invention also provides a primary medical platform. Referring to FIG. 6, FIG. 6 is a schematic structural view of a first embodiment of a primary medical platform according to the present invention. In the first embodiment of the present invention, the primary medical platform includes: a blood glucose monitoring module 10, configured to monitor a blood glucose value of the user at a preset time in a preset monitoring period according to a user medical treatment plan acquired from the network hospital platform; The comparison and statistics module 20 is configured to compare the blood glucose value of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and count the comparison result in the preset monitoring period; The plan sending module 30 is configured to determine a blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and send a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to perform the blood sugar adjusting plan.
本发明实施例所提出的基层医疗平台,可以是设置在乡镇、村等地的医疗机构,也可以是设置在社区或小区的社康、诊所等医疗机构,基层医疗平台中收集了该地或者该社区或小区的所有居民的基本信息以及该居民的病史等医疗信息,通过基层医疗平台对其所管辖的慢性病病人进行监控。本实施例中以基层医疗平台对糖尿病人监控的方法为例进行说明。The primary medical platform proposed by the embodiments of the present invention may be a medical institution installed in a township, a village, or the like, or may be a medical institution such as a social health clinic or a clinic set in a community or a community, and the primary medical platform collects the locality or The basic information of all residents of the community or community and the medical information such as the medical history of the resident are monitored by the primary medical platform for chronically ill patients under its jurisdiction. In this embodiment, a method for monitoring a diabetic person by a primary medical platform is taken as an example for description.
基层医疗平台的血糖监控模块10从网络医院平台获取用户对应的用户诊疗计划,该用户诊疗计划是在网络医院平台的数据库中存储的针对每个糖尿病人所形成的诊疗干预计划,诊疗计划中可包括用户在医院就诊时的确诊结果、对该用户进行血糖监控的监控周期和在该监控周期内所需采集血糖值的采集时间,以及针对用户的血糖值可能出现的所有情况而制定的血糖调整计划。基层医疗平台根据该用户诊疗计划中所预设的监控周期,例如监控一周内或10天内用户的血糖值,在该监控周期内对预设时间的血糖值进行监测,预设时间具体指为相应的用户所制定的血糖监测时间点。The blood glucose monitoring module 10 of the primary medical platform obtains the user's medical treatment plan corresponding to the user from the network hospital platform, and the user medical treatment plan is a medical treatment intervention plan formed for each diabetic person stored in the database of the network hospital platform, and the medical treatment plan can be It includes the diagnosis result of the user's visit to the hospital, the monitoring period of blood glucose monitoring for the user, the collection time of the blood glucose collected during the monitoring period, and the blood glucose adjustment for all possible conditions of the user's blood sugar level. plan. The primary medical platform monitors the blood glucose level of the user within a monitoring period according to a preset monitoring period in the user's medical treatment plan, for example, monitoring the blood glucose level of the user within one week or 10 days, and the preset time is specifically referred to as corresponding The user's blood glucose monitoring time point.
监测到用户在预设时间的血糖值后,基层医疗平台的在用户诊疗计划中匹配对应时间的血糖值阈值,对比及统计模块20将预设时间的血糖值与该时间对应的血糖值阈值进行对比,以确定用户在该时间的血糖值过高还是过低。对比及统计模块20还统计在预设的监控周期内的血糖值对比结果,以在该监控周期结束后分析该监控周期内的血糖监控结果。After monitoring the blood glucose level of the user at the preset time, the primary medical platform matches the blood glucose threshold of the corresponding time in the user's medical treatment plan, and the comparison and statistics module 20 performs the blood glucose level of the preset time and the blood glucose threshold corresponding to the time. Contrast to determine if the user's blood glucose level at this time is too high or too low. The comparison and statistics module 20 also counts the blood glucose value comparison results within a preset monitoring period to analyze the blood glucose monitoring results during the monitoring period after the monitoring period ends.
在一个监控周期结束后,基层医疗平台根据在该监控周期内的对比结果,确定该监控周期内的血糖监控结果,即根据在一个预设的监控周期内对用户在预设时间的血糖值的持续监控,确定在该监控周期内的血糖值是否稳定,是否持续高于血糖值阈值,或者持续低于血糖值阈值。确定了血糖监控结果,基层医疗平台根据血糖监控结果对应的情况,在用户诊疗计划中进行匹配,匹配出该血糖监控结果对应的血糖调整计划,计划发送模块30将其发送至用户,供用户按照血糖调整计划中的内容执行,以实现对用户的血糖值的基础监控以及对诊疗计划的执行情况的监控。本实施例中,血糖调整计划包括药物治疗方案、饮食方案、运动方案以及治疗周期中的至少一项。After the end of a monitoring period, the primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the monitoring period, that is, according to the blood glucose level of the user at the preset time within a preset monitoring period. Continuous monitoring to determine if the blood glucose level during the monitoring period is stable, whether it continues to be above the blood glucose threshold, or continues below the blood glucose threshold. The blood glucose monitoring result is determined, and the primary medical platform performs matching in the user diagnosis plan according to the situation corresponding to the blood glucose monitoring result, and matches the blood glucose adjustment plan corresponding to the blood glucose monitoring result, and the plan sending module 30 sends the blood glucose adjustment plan to the user for the user to follow. The content of the blood glucose adjustment plan is implemented to achieve basic monitoring of the user's blood glucose level and monitoring of the implementation of the treatment plan. In this embodiment, the blood glucose adjustment plan includes at least one of a drug treatment plan, a diet plan, an exercise program, and a treatment cycle.
本发明实施例通过基层医疗平台从网络医院平台获取用户诊疗计划,并在预设的监控周期内监测用户在预设时间的血糖值,将用户在预设时间的血糖值与用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果,根据该监控周期内的对比结果确定该监控周期内的血糖监控结果,向用户发送血糖监控结果对应的血糖调整计划,供用户执行血糖调整计划。通过基层医疗平台与网络医院平台的对接,根据用户诊疗计划对糖尿病患者进行相关的参数监测、提醒和执行干预,从而提高了对糖尿病患者的治疗进度和治疗效果。The embodiment of the invention acquires the user diagnosis and treatment plan from the network hospital platform through the primary medical platform, and monitors the blood glucose value of the user at the preset time in the preset monitoring period, and corresponds the blood glucose value of the user at the preset time to the user diagnosis plan. The blood glucose threshold of the time is compared, and the comparison result in the preset monitoring period is counted, the blood glucose monitoring result in the monitoring period is determined according to the comparison result in the monitoring period, and the blood glucose adjusting plan corresponding to the blood glucose monitoring result is sent to the user, Allows the user to perform a blood glucose adjustment program. Through the docking of the primary medical platform and the network hospital platform, relevant parameters monitoring, reminding and intervention intervention for diabetic patients are carried out according to the user's medical treatment plan, thereby improving the treatment progress and treatment effect for diabetic patients.
在上述实施例中,血糖监控模块10具体用于: 在预设的监控周期内,根据用户诊疗计划中的监测时间,发送采集指令至监测设备;In the above embodiment, the blood glucose monitoring module 10 is specifically configured to: Sending an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan during the preset monitoring period;
接收监测设备发送的用户的空腹血糖值和餐后血糖值,并在预设的监控周期内对空腹血糖值和餐后血糖值进行分析和管理。The fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device are received, and the fasting blood glucose value and the postprandial blood glucose value are analyzed and managed within a preset monitoring period.
基层医疗平台获取用户的用户诊疗计划后,血糖监控模块10在其中所预设的监控周期内,根据预设的每一天的监测时间,向用于采集用户血糖值的监测设备发送采集指令,监测设备采集用户的空腹血糖值和餐后血糖值,具体可优选采集用户在早晨进餐前的空腹血糖值和进食早餐两个小时后的餐后血糖值,监测设备将采集到的用户的空腹血糖值和餐后血糖值发送至基层医疗平台。血糖监控模块10以监控周期为单位,记录用户每天的空腹血糖值和餐后血糖值;并且对比每一次空腹血糖值和餐后血糖值与血糖值阈值,同时以监控周期为单位记录每次的对比结果,以根据对一个监控周期内的对比结果的统计情况,确定该监控周期内的血糖监控结果。After the primary medical platform obtains the user's medical treatment plan, the blood glucose monitoring module 10 sends an acquisition instruction to the monitoring device for collecting the user's blood sugar level according to the preset monitoring time of each day in the preset monitoring period, and monitors The device collects the fasting blood glucose value and the postprandial blood glucose value of the user, and specifically collects the fasting blood glucose value of the user before the meal in the morning and the postprandial blood glucose value after two hours of eating the breakfast, and the fasting blood glucose value of the user that the monitoring device will collect. And postprandial blood glucose values are sent to the primary care platform. The blood glucose monitoring module 10 records the fasting blood glucose level and the postprandial blood glucose value of the user every day in the monitoring period; and compares each fasting blood glucose value and the postprandial blood glucose value with the blood glucose threshold, and records each time in the monitoring period. The results are compared to determine the blood glucose monitoring results during the monitoring period based on the statistical results of the comparison results within one monitoring period.
在上述实施例中,计划发送模块30具体用于: 在预设的监控周期内,如空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值时,或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值时,确定不同情况所对应的血糖监控结果;In the above embodiment, the plan sending module 30 is specifically configured to: During a preset monitoring period, such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high When the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, determining corresponding conditions Blood glucose monitoring results;
在用户诊疗计划中匹配确定的血糖监控结果对应的血糖调整计划,并将匹配的血糖调整计划发送至用户,以供用户执行血糖调整计划。The blood glucose adjustment plan corresponding to the determined blood glucose monitoring result is matched in the user treatment plan, and the matched blood sugar adjustment plan is sent to the user for the user to perform the blood sugar adjustment plan.
基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果时,具体地,如在整个监控周期内,空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值,则可确定在该监控周期内对用户的血糖监控结果为血糖值持续高于或低于血糖值阈值;或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值,也可确定在该监控周期内对用户的血糖监控结果为血糖值持续高于或低于血糖值阈值,预设的次数可按照监控周期的天数进行相应设置,例如,监控周期为一周,则预设的次数可为4次,也就是说,在一周的监控周期内,如血糖值高于或低于血糖值阈值的次数大于4次,则可认为在该监控周期内对用户的血糖监控结果为血糖值持续高于或低于血糖值阈值。The primary medical platform determines the blood glucose monitoring result during the monitoring period according to the comparison result in the preset monitoring period, specifically, if the fasting blood glucose level is continuously higher or lower than the fasting blood glucose threshold value during the entire monitoring period, and / or the postprandial blood glucose level is continuously higher or lower than the postprandial blood glucose threshold, it can be determined that the blood glucose monitoring result for the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold; or, such as fasting blood glucose The value of the value above or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, and may also be determined The blood glucose monitoring result of the user during the monitoring period is that the blood glucose level is continuously higher or lower than the blood glucose threshold, and the preset number of times can be set according to the number of days of the monitoring period. For example, if the monitoring period is one week, the preset number of times may be 4 times, that is to say, during the monitoring period of one week, if the number of times the blood glucose level is higher or lower than the blood glucose threshold is greater than 4 times, the blood of the user during the monitoring period can be considered. The result of sugar monitoring is that the blood glucose level continues to be above or below the blood glucose threshold.
此外,如在整个监控周期内,用户的空腹血糖值和/或餐后血糖值保持稳定,并未高于或低于血糖值阈值,则可确定在该监控周期内对用户的血糖监控结果为血糖值稳定,在这种情况下,基层医疗平台只需记录用户的空腹血糖值和/或餐后血糖值以及血糖监控结果,也可向用户发送血糖监控结果为血糖值稳定的提示消息,并在下一个监控周期继续监控用户在预设时间的血糖值。In addition, if the user's fasting blood glucose level and/or postprandial blood glucose level remain stable throughout the monitoring period and are not above or below the blood glucose threshold, it may be determined that the blood glucose monitoring result for the user during the monitoring period is The blood glucose level is stable. In this case, the primary medical platform only needs to record the user's fasting blood glucose level and/or postprandial blood glucose value and blood glucose monitoring result, and can also send a prompt message to the user that the blood glucose monitoring result is stable blood sugar level, and The user's blood glucose level at the preset time is continuously monitored during the next monitoring cycle.
确定了在监控周期内对用户的血糖监控结果,基层医疗平台在用户诊疗计划中匹配所确定的血糖监控结果对应的血糖调整计划,匹配时,由于用户诊疗计划中存储有针对该用户的血糖值可能出现的所有情况的血糖调整计划,确定了用户的血糖监控结果后,基层医疗平台在用户诊疗计划中匹配相应的血糖监控结果所对应的血糖调整计划,通过计划发送模块30将该血糖调整计划发送至用户,具体可以文字、语音或视频等方式发送至用户的智能终端或用于采集用户血糖值的监测设备,以提醒用户按照血糖调整计划中的各方案进行治疗。The blood glucose monitoring result is determined for the user during the monitoring period, and the primary medical platform matches the determined blood glucose monitoring plan corresponding to the determined blood glucose monitoring result in the user medical treatment plan. When matching, the user's medical treatment plan stores the blood sugar level for the user. The blood glucose adjustment plan of all the cases that may occur, after determining the blood glucose monitoring result of the user, the primary medical platform matches the blood glucose adjustment plan corresponding to the corresponding blood glucose monitoring result in the user diagnosis plan, and the blood sugar adjustment plan is planned by the plan sending module 30. The method is sent to the user, and can be sent to the user's smart terminal or the monitoring device for collecting the user's blood sugar level by text, voice or video, etc., to remind the user to perform treatment according to each scheme in the blood sugar adjustment plan.
本实施例中,如用户的血糖监控结果是血糖值持续高于或低于血糖值阈值,则基层医疗平台通过计划发送模块30将该血糖监控结果上传至网络医院平台,供网络医院平台侧的医生进行分析和诊断,并根据分析和诊断的结果调整或重新生成血糖调整计划。In this embodiment, if the blood glucose monitoring result of the user is that the blood glucose level continues to be higher or lower than the blood glucose threshold, the primary medical platform uploads the blood glucose monitoring result to the network hospital platform through the plan sending module 30 for the network hospital platform side. The doctor performs analysis and diagnosis and adjusts or regenerates the blood glucose adjustment plan based on the results of the analysis and diagnosis.
参照图7,图7为本发明基层医疗平台第二实施例的结构示意图。 在本发明基层医疗平台第一实施例的基础上,第二实施例中,基层医疗平台还包括: 获取模块40,用于与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。Referring to FIG. 7, FIG. 7 is a schematic structural view of a second embodiment of a primary medical platform according to the present invention. On the basis of the first embodiment of the primary medical platform of the present invention, in the second embodiment, the primary medical platform further includes: The obtaining module 40 is configured to connect to the network hospital platform, and obtain a user medical treatment plan corresponding to the user according to related information of the user.
基层医疗平台在对其所管辖的糖尿病人进行监控前,首先通过获取模块40与网络医院平台连接,具体可通过输入登陆账号和登陆密码的方式请求连接至网络医院平台,在网络医院平台验证通过后,可根据所需获取的用户的相关信息,在网络医院中获取该用户对应的用户诊疗计划。用户的相关信息可包括用户的姓名、性别等基本信息,或者该用户在网络医院平台的唯一的挂号号码,或者包括用户所属地,或者所属社区或小区的居住信息,基层医疗平台根据这些相关信息,从网络医院平台获取对应于该用户的用户诊疗计划,以对该用户进行血糖监控。Before the primary health care platform monitors the diabetics under its jurisdiction, it first connects to the network hospital platform through the acquisition module 40. Specifically, it can request to connect to the network hospital platform by inputting the login account and login password, and verifying the network hospital platform. After that, the user's medical treatment plan corresponding to the user can be obtained in the network hospital according to the relevant information of the user that needs to be obtained. The related information of the user may include basic information such as the user's name, gender, or the unique registered number of the user on the network hospital platform, or the location of the user, or the living information of the community or the community, and the primary medical platform according to the related information. Obtaining a user diagnosis plan corresponding to the user from the network hospital platform to perform blood glucose monitoring on the user.
参照图8,图8为本发明基层医疗平台第三实施例的结构示意图。 在本发明基层医疗平台第一实施例的基础上,第三实施例中,基层医疗平台还包括: 标记及存储模块50,用于对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。Referring to FIG. 8, FIG. 8 is a schematic structural view of a third embodiment of a primary medical platform according to the present invention. On the basis of the first embodiment of the primary medical platform of the present invention, in the third embodiment, the primary medical platform further includes: The marking and storage module 50 is configured to mark and store the blood glucose value of the preset time above or below the blood glucose threshold.
接收到监测设备发送的用户的空腹血糖值和餐后血糖值,并与相应的血糖值阈值进行对比后,如血糖值高于或低于对应时间的血糖值阈值,则通过标记及存储模块50将该血糖值进行标记并存储,具体地,可通过颜色标记或突出显示的方式标记血糖值,并将其存储,以供日后查看时可清楚明了的反映出用户出现异常的血糖值对应的时间和血糖值的大小。本实施例中,针对每次所监测到的高于或低于血糖值阈值的血糖值,也可将其传输至网络医院平台,供网络医院平台侧的医生进行相关的统计和标记。After receiving the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and comparing with the corresponding blood glucose threshold, if the blood glucose value is higher or lower than the blood glucose threshold of the corresponding time, the marking and storage module 50 is passed. The blood glucose value is marked and stored. Specifically, the blood glucose value can be marked by color marking or highlighting, and stored for later time to clearly reflect the time corresponding to the abnormal blood sugar value of the user. And the size of the blood sugar level. In this embodiment, for each monitored blood glucose level above or below the blood glucose threshold, it can also be transmitted to the network hospital platform for the doctors on the network hospital platform side to perform relevant statistics and marking.
以上仅为本发明的优选实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书及附图内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。The above are only the preferred embodiments of the present invention, and are not intended to limit the scope of the invention, and the equivalent structure or equivalent process transformations made by the description of the present invention and the drawings are directly or indirectly applied to other related technical fields. The same is included in the scope of patent protection of the present invention.

Claims (15)

  1. 一种基于基层医疗平台的糖尿病人监控方法,其特征在于,所述监控方法包括以下步骤: A method for monitoring a diabetic person based on a primary medical platform, characterized in that the monitoring method comprises the following steps:
    基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值;The primary medical platform monitors the user's blood glucose level at a preset time in a preset monitoring period according to the user medical treatment plan obtained from the network hospital platform;
    基层医疗平台将用户在预设时间的血糖值与所述用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果;The primary medical platform compares the blood glucose level of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and counts the comparison result within the preset monitoring period;
    基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送所述血糖监控结果对应的血糖调整计划,供用户执行所述血糖调整计划。The primary medical platform determines the blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and sends a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user for the user to execute the blood sugar adjusting plan.
  2. 如权利要求1所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值的步骤之前,所述监控方法还包括:The method for monitoring a diabetic person based on a primary medical platform according to claim 1, wherein the primary medical platform monitors the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform. Before the step of blood sugar level, the monitoring method further includes:
    基层医疗平台与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The primary medical platform is connected with the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the relevant information of the user.
  3. 如权利要求1所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述当预设时间的血糖值超出对应时间的血糖值阈值时,基层医疗平台向用户发送血糖调整计划,供用户执行所述血糖调整计划的步骤之后,所述监控方法还包括步骤:The method for monitoring a diabetic person based on a primary medical platform according to claim 1, wherein when the blood glucose level of the preset time exceeds the blood glucose threshold of the corresponding time, the primary medical platform sends a blood glucose adjustment plan to the user for After the user performs the step of the blood glucose adjustment plan, the monitoring method further includes the steps of:
    基层医疗平台对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。The primary care platform marks and stores the blood glucose values for a preset time above or below the blood glucose threshold.
  4. 如权利要求1所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值的步骤具体包括:The method for monitoring a diabetic person based on a primary medical platform according to claim 1, wherein the primary medical platform monitors the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform. The steps of the blood sugar level specifically include:
    基层医疗平台在预设的监控周期内,根据用户诊疗计划中的监测时间,发送采集指令至监测设备;The primary medical platform sends an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan within a preset monitoring period;
    基层医疗平台接收监测设备发送的用户的空腹血糖值和餐后血糖值,并在预设的监控周期内对所述空腹血糖值和餐后血糖值进行分析和管理。The primary medical platform receives the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzes and manages the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
  5. 如权利要求4所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值的步骤之前,所述监控方法还包括:The method for monitoring a diabetic person based on a primary medical platform according to claim 4, wherein the primary medical platform monitors the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform. Before the step of blood sugar level, the monitoring method further includes:
    基层医疗平台与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The primary medical platform is connected with the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the relevant information of the user.
  6. 如权利要求4所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述当预设时间的血糖值超出对应时间的血糖值阈值时,基层医疗平台向用户发送血糖调整计划,供用户执行所述血糖调整计划的步骤之后,所述监控方法还包括步骤:The method for monitoring a diabetic person based on a primary medical platform according to claim 4, wherein when the blood glucose level of the preset time exceeds the blood glucose threshold of the corresponding time, the primary medical platform sends a blood glucose adjustment plan to the user for After the user performs the step of the blood glucose adjustment plan, the monitoring method further includes the steps of:
    基层医疗平台对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。The primary care platform marks and stores the blood glucose values for a preset time above or below the blood glucose threshold.
  7. 如权利要求1所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述基层医疗平台根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送所述血糖监控结果对应的血糖调整计划,供用户执行所述血糖调整计划的步骤具体包括:The method for monitoring a diabetes person based on a primary medical platform according to claim 1, wherein the primary medical platform determines a blood glucose monitoring result in the monitoring period according to a comparison result in a preset monitoring period, and sends the result to the user. The blood glucose adjustment plan corresponding to the blood glucose monitoring result, and the step for the user to perform the blood sugar adjustment plan specifically includes:
    在预设的监控周期内,如空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值时,或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值时,基层医疗平台确定不同情况所对应的血糖监控结果;During a preset monitoring period, such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high The primary medical platform determines different conditions when the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of postprandial blood glucose values above or below the postprandial blood glucose threshold is greater than a preset number of thresholds Corresponding blood glucose monitoring results;
    基层医疗平台在所述用户诊疗计划中匹配确定的所述血糖监控结果对应的血糖调整计划,并将匹配的所述血糖调整计划发送至用户,以供用户执行所述血糖调整计划。The primary medical platform matches the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user treatment plan, and sends the matched blood glucose adjustment plan to the user for the user to execute the blood sugar adjustment plan.
  8. 如权利要求7所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述基层医疗平台根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值的步骤之前,所述监控方法还包括:The method for monitoring a diabetes person based on a primary medical platform according to claim 7, wherein the primary medical platform monitors the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform. Before the step of blood sugar level, the monitoring method further includes:
    基层医疗平台与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The primary medical platform is connected with the network hospital platform, and the user diagnosis plan corresponding to the user is obtained according to the relevant information of the user.
  9. 如权利要求7所述的基于基层医疗平台的糖尿病人监控方法,其特征在于,所述当预设时间的血糖值超出对应时间的血糖值阈值时,基层医疗平台向用户发送血糖调整计划,供用户执行所述血糖调整计划的步骤之后,所述监控方法还包括步骤:The method for monitoring a diabetic person based on a primary medical platform according to claim 7, wherein when the blood glucose level of the preset time exceeds the blood glucose threshold of the corresponding time, the primary medical platform sends a blood glucose adjustment plan to the user for After the user performs the step of the blood glucose adjustment plan, the monitoring method further includes the steps of:
    基层医疗平台对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。The primary care platform marks and stores the blood glucose values for a preset time above or below the blood glucose threshold.
  10. 一种用于权利要求1所述的糖尿病人监控方法的基层医疗平台,其特征在于,所述基层医疗平台包括:A primary medical platform for use in a method for monitoring a diabetic person according to claim 1, wherein the primary medical platform comprises:
    血糖监控模块,用于根据从网络医院平台获取的用户诊疗计划,在预设的监控周期内监测用户在预设时间的血糖值;The blood glucose monitoring module is configured to monitor a blood glucose value of the user at a preset time in a preset monitoring period according to the user medical treatment plan acquired from the network hospital platform;
    对比及统计模块,用于将用户在预设时间的血糖值与所述用户诊疗计划中对应时间的血糖值阈值进行对比,并统计预设的监控周期内的对比结果;The comparison and statistics module is configured to compare the blood glucose value of the user at the preset time with the blood glucose threshold of the corresponding time in the user's medical treatment plan, and compare the comparison result in the preset monitoring period;
    计划发送模块,用于根据预设的监控周期内的对比结果,确定该监控周期内的血糖监控结果,向用户发送所述血糖监控结果对应的血糖调整计划,供用户执行所述血糖调整计划。The plan sending module is configured to determine a blood glucose monitoring result in the monitoring period according to the comparison result in the preset monitoring period, and send a blood glucose adjusting plan corresponding to the blood glucose monitoring result to the user, where the user performs the blood sugar adjusting plan.
  11. 如权利要求10所述的基层医疗平台,其特征在于,所述基层医疗平台还包括:The primary medical platform of claim 10, wherein the primary medical platform further comprises:
    获取模块,用于与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The obtaining module is configured to connect with the network hospital platform, and obtain the user medical treatment plan corresponding to the user according to the related information of the user.
  12. 如权利要求10所述的基层医疗平台,其特征在于,所述血糖监控模块具体用于:The primary medical platform according to claim 10, wherein the blood glucose monitoring module is specifically configured to:
    在预设的监控周期内,根据用户诊疗计划中的监测时间,发送采集指令至监测设备;Sending an acquisition instruction to the monitoring device according to the monitoring time in the user's medical treatment plan during the preset monitoring period;
    接收监测设备发送的用户的空腹血糖值和餐后血糖值,并在预设的监控周期内对所述空腹血糖值和餐后血糖值进行分析和管理。Receiving the fasting blood glucose value and the postprandial blood glucose value of the user sent by the monitoring device, and analyzing and managing the fasting blood glucose value and the postprandial blood glucose value within a preset monitoring period.
  13. 如权利要求10所述的基层医疗平台,其特征在于,所述计划发送模块具体用于:The primary medical platform according to claim 10, wherein the plan sending module is specifically configured to:
    在预设的监控周期内,如空腹血糖值连续高于或低于空腹血糖值阈值,和/或餐后血糖值连续高于或低于餐后血糖值阈值时,或者,如空腹血糖值高于或低于空腹血糖值阈值的次数大于预设的次数阈值,和/或餐后血糖值高于或低于餐后血糖值阈值的次数大于预设的次数阈值时,确定不同情况所对应的血糖监控结果;During a preset monitoring period, such as when the fasting blood glucose level is continuously above or below the fasting blood glucose threshold, and/or the postprandial blood glucose level is continuously above or below the postprandial blood glucose threshold, or if the fasting blood glucose is high When the number of times below or below the fasting blood glucose threshold is greater than a preset number of thresholds, and/or the number of times the postprandial blood glucose value is higher or lower than the postprandial blood glucose threshold is greater than a preset number of thresholds, determining corresponding conditions Blood glucose monitoring results;
    在所述用户诊疗计划中匹配确定的所述血糖监控结果对应的血糖调整计划,并将匹配的所述血糖调整计划发送至用户,以供用户执行所述血糖调整计划。Matching the determined blood glucose adjustment plan corresponding to the blood glucose monitoring result in the user treatment plan, and transmitting the matched blood sugar adjustment plan to the user for the user to execute the blood sugar adjustment plan.
  14. 如权利要求13所述的基层医疗平台,其特征在于,所述基层医疗平台还包括:The primary medical platform according to claim 13, wherein the primary medical platform further comprises:
    获取模块,用于与网络医院平台连接,根据用户的相关信息获取该用户对应的用户诊疗计划。The obtaining module is configured to connect with the network hospital platform, and obtain the user medical treatment plan corresponding to the user according to the related information of the user.
  15. 如权利要求13所述的基层医疗平台,其特征在于,所述基层医疗平台还包括:The primary medical platform according to claim 13, wherein the primary medical platform further comprises:
    标记及存储模块,用于对高于或低于血糖值阈值的预设时间的血糖值进行标记并存储。A marking and storage module for marking and storing blood glucose values for a preset time above or below a blood glucose threshold.
PCT/CN2015/085625 2015-05-23 2015-07-30 Primary-level medical platform and diabetes patient monitoring method based on primary-level medical platform WO2016187950A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510268227.9 2015-05-23
CN201510268227.9A CN104899816A (en) 2015-05-23 2015-05-23 Primary medical platform and diabetes patient monitoring method based on same

Publications (1)

Publication Number Publication Date
WO2016187950A1 true WO2016187950A1 (en) 2016-12-01

Family

ID=54032464

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/085625 WO2016187950A1 (en) 2015-05-23 2015-07-30 Primary-level medical platform and diabetes patient monitoring method based on primary-level medical platform

Country Status (2)

Country Link
CN (1) CN104899816A (en)
WO (1) WO2016187950A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107714048A (en) * 2017-10-10 2018-02-23 北京平糖移动互联医疗科技有限公司 A kind of blood sugar monitoring intelligent reminding system and method
CN108461156A (en) * 2018-02-02 2018-08-28 重庆艾维迪生物科技有限公司 A kind of slow sick management-control method and its device, system based on Internet of Things
CN109192291A (en) * 2018-09-18 2019-01-11 北京嘉和美康信息技术有限公司 A kind of processing method and relevant apparatus of sign data
CN113140313A (en) * 2020-01-19 2021-07-20 浙江爱多特大健康科技有限公司 Blood glucose detection data processing method, device, equipment and computer storage medium
CN112489806B (en) * 2020-11-27 2022-02-15 南通市第一人民医院 Intelligent management method and system for disease state information of diabetic foot patient
CN112967769B (en) * 2021-03-19 2023-01-24 上海国药医药零售有限公司 Data processing and data evaluation method for chain pharmacy diabetes follow-up visit data

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1244104A (en) * 1997-01-20 2000-02-09 卡佩迭姆保健有限社团 Apparatus and system for the telematic control of physiological parameters of patients
CN103226647A (en) * 2012-11-30 2013-07-31 天津唐虞科技发展有限公司 Health data management system and method based on network
CN104239415A (en) * 2014-08-18 2014-12-24 成都正广兴健康咨询有限公司 Health information data monitoring system and monitoring method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5266221B2 (en) * 2006-08-08 2013-08-21 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Method and apparatus for monitoring physiological parameters
CN102184312B (en) * 2011-03-15 2013-07-31 温州医学院眼视光研究院 Internet-of-things based medical management monitoring system
CN104361229A (en) * 2014-11-11 2015-02-18 姚定国 Follow-up interaction system for diabetes doctor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1244104A (en) * 1997-01-20 2000-02-09 卡佩迭姆保健有限社团 Apparatus and system for the telematic control of physiological parameters of patients
CN103226647A (en) * 2012-11-30 2013-07-31 天津唐虞科技发展有限公司 Health data management system and method based on network
CN104239415A (en) * 2014-08-18 2014-12-24 成都正广兴健康咨询有限公司 Health information data monitoring system and monitoring method thereof

Also Published As

Publication number Publication date
CN104899816A (en) 2015-09-09

Similar Documents

Publication Publication Date Title
WO2016187950A1 (en) Primary-level medical platform and diabetes patient monitoring method based on primary-level medical platform
WO2016187957A1 (en) Primary-level medical platform and hypertension patient monitoring method based on primary-level medical platform
WO2016109986A1 (en) Health management based online doctor-patient interaction system and interaction method
WO2016101351A1 (en) Network hospital based general practitioner auxiliary diagnosis and treatment system and method
Dillingham et al. Establishing high‐quality reference values for nerve conduction studies: a report from the normative data task force of the American Association of Neuromuscular & Electrodiagnostic Medicine
WO2016086442A1 (en) Network hospital-based dermatology remote screening system and method
WO2013035902A1 (en) Health care system based on video in remote health care solution and method for providing health care service
WO2016206178A1 (en) Health report query method and system in o2o mode
WO2019127848A1 (en) Underwriting method, underwriting device, insurance verificationi and storage medium
WO2017012200A1 (en) Electronic diagnosis letter-based medical institution identification method and network hospital platform
WO2019104877A1 (en) Method, apparatus and device for connection to insurance purchase through website and medium
Gokul et al. The natural history of corneal topographic progression of keratoconus after age 30 years in non-contact lens wearers
WO2017012179A1 (en) Electronic diagnosis letter generating method in o2o model and network hospital platform
EP3407781A1 (en) Sensor-based detection of changes in health and ventilation threshold
TWI657799B (en) Electronic apparatus and method for providing skin detection information thereof
US9737265B2 (en) Adaptive notch filter
JP2017501777A (en) A processor for processing skin conductance data and a device for detecting at least one stage of a burnout and / or chronic fatigue syndrome of an organism
WO2019039808A1 (en) Device, method, and program for predicting hypoglycemia and device, method, and program for producing hypoglycemia predicting model
WO2016026298A1 (en) Screen display method and device, and screen
EP3419519A1 (en) Improving performance of biological measurements in the presence of noise
Tang et al. Baseline detrending for the photopic negative response
WO2016187951A1 (en) Primary-level medical platform and heart disease patient monitoring method based on primary-level medical platform
Jankelowitz et al. Pathophysiology of HNPP explored using axonal excitability
CN113835660A (en) Display screen adjusting method and device, computer equipment and storage medium
WO2016179903A1 (en) Network hospital platform, expert platform and expert consultation request method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15893031

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15893031

Country of ref document: EP

Kind code of ref document: A1